The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

被引：0

作者：

Sharmin, Sifat ^{[1
,2
]}

Roos, Izanne ^{[1
,3
]}

Simpson-Yap, Steve ^{[1
,4
,5
]}

Malpas, Charles ^{[1
,3
]}

Lechner-Scott, Jeannette ^{[6
]}

Buzzard, Katherine ^{[7
]}

Skibina, Olga ^{[7
]}

van der Walt, Anneke ^{[8
]}

Butzkueven, Helmut ^{[8
]}

Kermode, Allan ^{[9
]}

Butler, Ernest ^{[10
]}

Barnett, Michael ^{[10
]}

Hodgkinson, Suzanne ^{[11
]}

McCombe, Pamela ^{[12
,13
,14
]}

Taylor, Bruce ^{[15
]}

Slee, Mark ^{[16
]}

Macdonell, Richard ^{[17
]}

Garber, Justin ^{[18
]}

Shaw, Cameron ^{[19
]}

Shuey, Neil ^{[20
]}

Massey, Jennifer ^{[21
]}

Hardy, Todd ^{[22
]}

Parratt, John ^{[23
]}

Kalincik, Tomas ^{[1
,3
]}

机构：

[1] Univ Melbourne, Dept Med, CORe, Melbourne, Australia

[2] Royal Melbourne Hosp, Dept Neurol, Neuroimmunol Ctr, Melbourne, Australia

[3] Royal Melbourne Hosp, Dept Neurol, Melbourne MS Ctr, Melbourne, Australia

[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Australia

[5] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia

[6] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, Australia

[7] Box Hill Hosp, Dept Neurol, Melbourne, Australia

[8] Alfred Hosp, Dept Neurol, Melbourne, Australia

[9] Univ Western Australia, Perron Inst, Nedlands, Australia

[10] Monash Med Ctr, Melbourne, Australia

[11] Brain & Mind Ctr, Sydney, NSW, Australia

[12] Liverpool Hosp, Sydney, Australia

[13] Univ Queensland, Brisbane, Australia

[14] Royal Brisbane & Womens Hosp, Brisbane, Australia

[15] Royal Hobart Hosp, Hobart, Australia

[16] Flinders Univ S Australia, Adelaide, SA, Australia

[17] Austin Hlth, Melbourne, Australia

[18] Westmead Hosp, Sydney, Australia

[19] Geelong Hosp, Geelong, Australia

[20] St Vincents Hosp, Fitzroy, Australia

[21] St Vincents Hosp Sydney, Sydney, Australia

[22] Concord Repatriat Gen Hosp, Sydney, Australia

[23] Royal North Shore Hosp, Sydney, Australia

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 04期

关键词：

secondary progressive multiple sclerosis; disease modifying therapy; latitude; geography; health expenditure;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：6 / 6

页数：1

共 50 条

[41] Secondary Progressive Multiple Sclerosis: Definition and Measurement
Domenico Plantone
Floriana De Angelis
Anisha Doshi
Jeremy Chataway
CNS Drugs, 2016, 30 : 517 - 526
[42] Siponimod to treat secondary progressive multiple sclerosis
Gajofatto, A.
Turatti, M.
DRUGS OF TODAY, 2020, 56 (01) : 37 - 46
[43] MRI Activity in Secondary Progressive Multiple Sclerosis
Zohar, Daniela Noa
Achiron, Anat
NEUROLOGY, 2020, 94 (15)
[44] MRI aspects of secondary progressive multiple sclerosis
Wolinsky, JS
MULTIPLE SCLEROSIS, 2002, 8 (01): : 85 - 87
[45] Siponimod for active secondary progressive multiple sclerosis
Gaber, Tarek
PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (02) : 4 - 5
[46] Immunological aspects of secondary progressive multiple sclerosis
Weiner, LP
Kachuck, NJ
Gilmore, W
Lund, B
MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (01) : 83 - 84
[47] The natural history of secondary progressive multiple sclerosis
Koch, Marcus
Kingwell, Elaine
Rieckmann, Peter
Tremlett, Helen
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (09): : 1039 - 1043
[48] Functional MRI in secondary progressive multiple sclerosis
Gavazzi, C
Rocca, MA
Mezzapesa, DM
Falini, A
Colombo, B
Mascalchi, M
Scotti, G
Comi, G
Filippi, M
RIVISTA DI NEURORADIOLOGIA, 2003, 16 : 250 - 250
[49] Secondary Progressive Multiple Sclerosis: Definition and Measurement
Plantone, Domenico
De Angelis, Floriana
Doshi, Anisha
Chataway, Jeremy
CNS DRUGS, 2016, 30 (06) : 517 - 526
[50] THE RISK OF SEIZURES IN PROGRESSIVE MULTIPLE SCLEROSIS
Howell, O. W.
Nicholas, R.
Gveric, D.
Rees, M. I.
Roncaroli, F.
Reynolds, R.
EPILEPSIA, 2012, 53 : 24 - 25

← 1 2 3 4 5 →